2023 - Taking a proactive and holistic approach to diversity assessment and planning

How to strategically plan and implement tactics to drive diversity in clinical research
Many patients groups are underrepresented in clinical research, which impacts the ability to study the effectiveness of a treatment on people of different ages, races and ethnicities. Regulatory agencies are advising on more robust planning to improve clinical trial diversity and advancing health equity as outlined in the Food & Drug Omnibus Reform Act (FDORA) 29 Dec 2022 and referenced in the recent US Food & Drug Administration (FDA) guidance on decentralised clinical trials on 2 May.
This webinar will present and discuss strategies to proactively assess and implement diversity in clinical trial planning, partnering with sponsors and research sites to ensure the best outcomes. Experts from patient recruitment, site networks and in-home services discuss how a patient-centric approach will increase diversity while minimising burden, for patients and study teams alike.
Participants will learn the following during the webinar —
Outlining diversity goals:
Defining target populations
Conducting situational analysis
Thinking beyond race & ethnicity
Identifying patient-centric enrolment barriers and operational challenges:
Evaluating the protocol
Conducting SWOT analysis through patient insights
Register for this webinar to discover patient-centric approaches that will increase diversity while minimising burden, for patients and study teams alike.